Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain
Clinical trial NCT03282149 · COMPLETED
Trial details
- NCT number
- NCT03282149
- Sponsor
- Xalud Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-21
- Primary completion
- 2019-03-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.